From the Guidelines
Vtama, assuming it refers to a vitamin D analogue, typically shows improvement in psoriasis symptoms within 2-12 weeks of starting treatment, with more significant clearing occurring after consistent use. The duration of psoriasis healing with Vtama can vary based on the specific formulation, treatment regimen, and individual patient response. According to the guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures 1, the long-term use of topical vitamin D analogues, including calcipotriene, calcitriol, tacalcitol, and maxacalcitol, is recommended for the treatment of mild to moderate psoriasis for up to 52 weeks. Some key points to consider when using Vtama for psoriasis treatment include:
- The application of vitamin D analogues twice daily on weekdays in conjunction with high-potency topical corticosteroids twice daily on weekends can be considered for maintenance treatment for psoriasis 1.
- The use of combination treatments with vitamin D analogues and potent class II and class III topical corticosteroids up to 52 weeks is recommended for the treatment of psoriasis 1.
- Topical vitamin D analogues combined with betamethasone dipropionate can be used for the treatment of nail psoriasis to reduce nail thickness, hyperkeratosis, onycholysis, and pain 1. It's essential to follow the treatment regimen and dosage recommended by your healthcare provider, as individual results may vary based on psoriasis severity, affected body areas, and adherence to the treatment regimen. Additionally, it's crucial to note that Vtama, or vitamin D analogues, should not be used in combination with salicylic acid, as the acid pH of salicylic acid can inactivate the vitamin D analogue and reduce its effectiveness 1. Overall, Vtama can be an effective treatment option for psoriasis, but it's essential to work closely with your healthcare provider to determine the best treatment plan for your individual needs.
From the Research
Psoriasis Healing Duration with Vtama
- The exact duration of psoriasis healing with Vtama (possibly referring to a vitamin or treatment, assuming Vitama or a similar treatment) is not directly stated in the provided studies.
- However, a study on Tapinarof (Vtama), a novel topical treatment for plaque psoriasis in adults, was approved by the US Food and Drug Administration in May 2022 2.
- The study on Tapinarof does not provide specific information on the duration of psoriasis healing, but it discusses the efficacy and safety of the treatment.
- Other studies provide information on the duration of treatment and healing rates for different psoriasis treatments, such as:
- Combination treatment with methotrexate and cyclosporin, with a mean duration of combination treatment of 18.9 +/- 15.7 weeks for short-term treatment and 193.2 +/- 160.6 weeks for long-term treatment 3.
- Biologic agents, with varying durations of effect, including alefacept (29.9 weeks), ustekinumab (22 weeks), infliximab (19.5 weeks), adalimumab (18 weeks), etanercept (12.1 weeks), and efalizumab (9.6 weeks) 4.
- Methotrexate and ciclosporin combination therapy, with a median duration of combination therapy of 9.5 weeks (range 4-50) 5.
- Maintenance of response to psoriasis treatments, with long-term response rates ranging from 18.7% to 65.2% at 1 year, depending on the medication 6.